| Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases AA Joharapurkar, VB Pandya, VJ Patel, RC Desai, MR Jain Journal of medicinal chemistry 61 (16), 6964-6982, 2018 | 157 | 2018 |
| Antinociceptive activity of alcoholic extract of Hemidesmus indicus R. Br. in mice PR Verma, AA Joharapurkar, VA Chatpalliwar, AJ Asnani Journal of Ethnopharmacology 102 (2), 298-301, 2005 | 157 | 2005 |
| In vivo evaluation of antioxidant activity of alcoholic extract of Rubia cordifolia Linn. and its influence on ethanol-induced immunosuppression AA Joharapurkar, SP Zambad, MM Wanjari, SN Umathe Indian journal of pharmacology 35 (4), 232-236, 2003 | 138 | 2003 |
| Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: Synthesis, biological evaluation, and molecular modeling … BK Srivastava, A Joharapurkar, S Raval, JZ Patel, R Soni, P Raval, A Gite, ... Journal of medicinal chemistry 50 (24), 5951-5966, 2007 | 80 | 2007 |
| Pathophysiological mechanism of bone loss in type 2 diabetes involves inverse regulation of osteoblast function by PGC-1α and skeletal muscle atrogenes: AdipoR1 as a potential … MP Khan, AK Singh, AA Joharapurkar, M Yadav, S Shree, H Kumar, ... Diabetes 64 (7), 2609-2623, 2015 | 69 | 2015 |
| Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity AA Joharapurkar, NA Dhanesha, MR Jain Diabetes, metabolic syndrome and obesity: targets and therapy, 73-84, 2014 | 64 | 2014 |
| Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors D Patel, M Jain, SR Shah, R Bahekar, P Jadav, A Joharapurkar, ... Bioorganic & medicinal chemistry letters 22 (2), 1111-1117, 2012 | 62 | 2012 |
| Role of mineralocorticoid receptor antagonists in kidney diseases V Patel, A Joharapurkar, M Jain Drug development research 82 (3), 341-363, 2021 | 54 | 2021 |
| Effect of GLP-1 based therapies on diabetic dyslipidemia V J Patel, A A Joharapurkar, G B Shah, M R Jain Current diabetes reviews 10 (4), 238-250, 2014 | 53 | 2014 |
| 11 β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome A Joharapurkar, N Dhanesha, G Shah, R Kharul, M Jain Pharmacological reports 64 (5), 1055-1065, 2012 | 47 | 2012 |
| Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect N Dhanesha, A Joharapurkar, G Shah, V Dhote, S Kshirsagar, R Bahekar, ... Pharmacological Reports 64 (1), 140-149, 2012 | 42 | 2012 |
| Anti-inflammatory activity of Martynia diandra glox VA Chatpalliwar, AA Joharapurkar, MM Wanjari, RR Chakraborty, ... Indian Drugs 39 (10), 543-545, 2002 | 42 | 2002 |
| Exendin‐4 ameliorates diabetic symptoms through activation of glucokinase N Dhanesha, A Joharapurkar, G Shah, V Dhote, S Kshirsagar, R Bahekar, ... Journal of diabetes 4 (4), 369-377, 2012 | 41 | 2012 |
| Immunomodulatory activity of alcoholic extract of Rubia cordifolia Linn. AA Joharapurkar, NM Deode, SP Zambad, SN Umathe Indian Drugs 40 (3), 179-181, 2003 | 41 | 2003 |
| Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice V Patel, A Joharapurkar, N Dhanesha, S Kshirsagar, K Patel, R Bahekar, ... Canadian Journal of Physiology and Pharmacology 91 (12), 1009-1015, 2013 | 40 | 2013 |
| Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effect BK Srivastava, R Soni, JZ Patel, A Joharapurkar, N Sadhwani, ... Bioorganic & medicinal chemistry letters 19 (9), 2546-2550, 2009 | 40 | 2009 |
| Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats V Dhote, A Joharapurkar, S Kshirsagar, N Dhanesha, V Patel, A Patel, ... Clinical and Experimental Pharmacology and Physiology 38 (5), 338-344, 2011 | 38 | 2011 |
| Optimization of 1, 2, 5‐thiadiazole carbamates as potent and selective ABHD6 inhibitors JZ Patel, TJ Nevalainen, JR Savinainen, Y Adams, T Laitinen, RS Runyon, ... ChemMedChem 10 (2), 253-265, 2015 | 37 | 2015 |
| Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in … AK Singh, AA Joharapurkar, MP Khan, JS Mishra, N Singh, M Yadav, ... Diabetes 63 (10), 3530-3544, 2014 | 37 | 2014 |
| Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia AA Joharapurkar, VV Dhote, MR Jain Journal of medicinal chemistry 55 (12), 5649-5675, 2012 | 37 | 2012 |
Dr. Mukul JainPresident at Zydus Research Centre, Ahmedabad, IndiaVerified email at zyduscadila.com
